Biochip Market is Anticipated To Reach $25.8 Billion By 2024
“The Global Biochip Market was valued at USD 7.63 billion in 2015. apid technological advancements in the biochips market along with high market demand from proteomic and genomic applications is expected to drive market growth.�
The Global Biochips Market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements in the biochips market along with high market demand from proteomic and genomic applications is expected to drive market growth. Access Full Research Report on Global Biochips Market : http://www.grandviewresearch.com/industry-analysis/biochips-market Anticipated launch and commercialization of novel products for diagnosis and treatment including laboratory- and non-laboratory-based research are expected to further reinforce growth in demand. Improvements in accuracy, resolution, and preparation procedures for the technology coupled with reduction in costs of associated materials are expected to fuel growth over the forecast period. Ongoing developments related to further miniaturization of biochips are expected to enhance their applicability and additional usage for genetic sequencing methodologies,
Follow Us:
such as cancer genomics. Their usage is also expected to aid reduction in the cost of genome profiling, which is a factor likely to drive demand for the next step of genetic analysis, i.e., protein expression analysis. Consequently, a growth in the number of such protein profiling studies is expected to directly fuel demand for genomic and proteomic labeling techniques through to 2024. Further key findings from the study suggest:
DNA chips form the largest revenue-generating segment of the biochip applications. Major contribution to this share comes from usage in cancer diagnostics/treatment and drug discovery applications. DNA chips accounted for around a third of the global market revenue in 2015. The other notable contributing segments to application of biochips include gene expression, single nucleotide polymorphism genotyping, genomic studies, and agricultural biotechnology.
The market is expected to have a high potential for growth as the technology has numerous applications to aid the miniaturization of molecular biology and biochemical & chemical assays. Over time, such miniaturization is expected to benefit medical technologies in terms of cost and input requirements.
DNA chips, lab-on-a-chip, protein chips, and tissue & cell arrays find a number of uses in pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic centers, and other end users like point-of-care settings, forensic labs, blood banks, etc.
North America was the largest revenue-generating region and accounted for over 45%of total revenue in 2015. This can be attributed to by the presence of government initiatives for personalized patient care coupled with the availability of a very large installed base of genetic and proteomic profiling platforms across the U.S. High market usage of next-gen sequencing techniques for molecular diagnosis and treatment used with microfluidic techniques also add to the large share. Furthermore, cancer analysis projects in a number of academic and clinical research institutes are also responsible for the region’s large share.
Some key players operating in this industry include Abbott Laboratories; PerkinElmer, Inc.; GE Healthcare; Illumina, Inc.; Thermo Fisher Scientific, Inc.;
Follow Us:
Merck Millipore; Agilent Technologies, Inc.; Sigma-Aldrich Corporation; Fluidigm Corporation; and Bio-Rad Laboratories, Inc. Grand View Research has segmented the Biochip Market on the basis of type, end use, region: Read Our Blogs on Reports from this category By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare Table of Content of Global Biochip Market Research Report: Chapter 1 Methodology and Scope 1.1 Research Methodology 1.2 Research Scope & Assumptions 1.3 List of Data Sources Chapter 2 Executive Summary Chapter 3 Biochip Industry Outlook 3.1 Market Segmentation 3.2 Market Size and Growth prospects, 2013 - 2024 3.3 Biochip Market Dynamics 3.3.1 Market driver analysis 3.3.1.1 Increase in adoption of next-generation sequencing 3.3.1.2 Growing R&D in proteomics and genomics 3.3.1.3 Presence of an extensive drug-development pipeline 3.3.1.4 Increasing adoption of personalized medicine 3.3.1.5 Rapid technological advances in biochip technology 3.3.2 Market restraint analysis 3.3.2.1 High cost of manufacturing 3.4 Key Opportunities Prioritized,2015 3.6 Industry Analysis - Porter’s 3.7 Biochip PESTEL Analysis
Follow Us:
Chapter 4 Biochip Type Outlook 4.1 Global Biochip Revenue Share, by Product, 2015 & 2024 4.2 DNA Chips, by Application 4.2.1 DNA chips market, 2013 - 2024 (USD Million) 4.2.2 Cancer diagnosis and treatment 4.2.2.1 Cancer diagnosis and treatment market, 2013 - 2024 (USD Million) 4.2.3 Gene expression 4.2.3.1 Gene expression market, 2013 - 2024 (US Million) 4.2.4 Single nucleotide polymorphism (SNP) genotyping 4.2.4.1 SNP genotyping market, 2013 - 2024 (USD Million) 4.2.5 Genomics 4.2.5.1 Genomics market, 2013 - 2024 (USD Million) 4.2.6 Drug discovery 4.2.6.1 Drug discovery market, 2013 - 2024 (USD Million) 4.2.7 Agricultural biotechnology 4.2.7.1 Agricultural biotechnology market, 2013 - 2024 (USD Million) 4.2.8 Others 4.2.8.1 Other markets, 2013 - 2024 (USD Million) 4.3 Lab-On-a-Chip, by Application 4.3.1 Lab-on-a-chip market, 2013 - 2024 (USD Million) 4.3.2 Clinical diagnostics 4.3.2.1 Clinical diagnostics market, 2013 - 2024 (USD Million) 4.3.3 Genomics 4.3.3.1 Genomics market, 2013 - 2024 (USD Million) 4.3.4 In vitro diagnosis (IVD) & point-of-care (POC) 4.3.4.1 IVD & POC market, 2013 - 2024 (USD Million)
Follow Us:
4.3.5 Proteomics 4.3.5.1 Proteomics market, 2013 - 2024 (USD Million) 4.3.6 Drug discovery 4.3.6.1 Drug discovery market, 2013 - 2024 (USD Million) 4.3.7 Others 4.3.7.1 Others market, 2013 - 2024 (USD Million) 4.4 Protein Chips, by Application 4.4.1 Protein chips market, 2013 - 2024 (USD Million) 4.4.2 Proteomics 4.4.2.1 Proteomics market, 2013 - 2024 (USD Million) 4.4.3 Expression profiling 4.4.3.1 Expression profiling market, 2013 - 2024 (USD Million) 4.4.4 Diagnostics 4.4.4.1 Diagnostics market, 2013 - 2024 (USD Million) 4.4.5 High Throughput Screening (HTS) 4.4.5.1 HTS market, 2013 - 2024 (USD Million) 4.4.6 Drug discovery 4.4.6.1 Drug discovery market, 2013 - 2024 (USD Million) 4.4.7 Others 4.4.7.1 Others market, 2013 - 2024 (USD Million) 4.5 Others 4.5.1 Other market, 2013 - 2024 (USD Million) 4.5.2 Tissue arrays 4.5.2.1 Tissue arrays market, 2013 - 2024 (USD Million) 4.5.3 Cell arrays 4.5.3.1 Cell arrays market, 2013 - 2024 (USD Million) Chapter 5 Biochip End-Use Outlook
Follow Us:
5.1 Global Biochip Revenue Share by End Use, 2015 & 2024 5.2 Biotechnology and Pharmaceutical Companies 5.2.1 Biotechnology and pharmaceutical companies market, 2013 2024 (USD Million) 5.3 Hospitals and Diagnostics Centers 5.3.1 Hospitals and diagnostics centers market, 2013 - 2024 (USD Million) 5.4 Academic & Research Institutes 5.4.1 Academic & research institutes market, 2013 - 2024 (USD Million) 5.5 Others 5.5.1 Others market, 2013 - 2024 (USD Million) Chapter 7 Biochip Regional Outlook 7.1 Global Biochip Revenue Share, By Region, 2015&2024 7.2 North America 7.2.1 North America biochip market, 2013 - 2024 (USD Million) 7.2.2 U.S. 7.2.2.1 U.S. biochip market, 2013 - 2024 (US Million) 7.2.3 Canada 7.2.3.1 Canada biochip market, 2013 - 2024 (US Million) 7.3 Europe 7.3.1 Europe biochip market, 2013 - 2024 (USD Million) 7.3.2 Germany 7.3.2.1 Germany biochip market, 2013 - 2024(USD Million) 7.3.3 UK 7.3.3.1 UK biochip market, 2013 - 2024 (US Million) 7.4 Asia Pacific 7.4.1 Asia Pacific biochip market, 2013 - 2024 (USD Million)
Follow Us:
7.4.2 Japan 7.4.2.1 Japan biochip market, 2013 - 2024 (US Million) 7.4.3 China 7.4.3.1 China biochip market, 2013 - 2024 (US Million) 7.5 Latin America 7.5.1 Latin America biochip market, 2013 - 2024 (USD Million) 7.5.2 Brazil 7.5.2.1 Brazil biochip market, 2013 - 2024 (US Million) 7.6 MEA 7.6.1 MEA biochip market, 2013 - 2024 (USD Million) 7.6.2 South Africa 7.6.2.1 South Africa biochip market, 2013 - 2024 (USD Million) Chapter 8 Competitive Landscape 8.1 Abbott Laboratories 8.1.1 Company overview 8.1.1 Financial performance 8.1.2 Product benchmarking 8.1.3 Strategic initiatives 8.2 Agilent Technologies, Inc. 8.2.1 Company overview 8.2.2 Financial performance 8.2.3 Product benchmarking 8.2.4 Strategic initiatives 8.3 PerkinElmer, Inc. 8.3.1 Company overview 8.3.2 Financial performance 8.3.3 Product benchmarking
Follow Us:
8.3.4 Strategic initiatives 8.4 Fluidigm Corporation 8.4.1 Company overview 8.4.2 Financial performance 8.4.3 Product benchmarking 8.4.4 Strategic initiatives 8.5 Illumina, Inc. 8.5.1 Company overview 8.5.2 Financial performance 8.5.3 Product benchmarking 8.5.4 Strategic initiatives 8.6 GE Healthcare 8.6.1 Company overview 8.6.2 Financial performance 8.6.3 Product benchmarking 8.6.4 Strategic initiatives 8.7 Bio-Rad Laboratories, Inc. 8.7.1 Company overview 8.7.2 Financial performance 8.7.3 Product benchmarking 8.7.4 Strategic initiatives 8.8 Thermo Fisher Scientific, Inc. 8.8.1 Company overview 8.8.2 Financial performance 8.8.3 Product benchmarking 8.8.4 Strategic initiatives 8.9 LI-COR, Inc.
Follow Us:
8.9.1 Company overview 8.9.2 Financial performance 8.9.3 Product benchmarking 8.9.4 Strategic initiatives 8.10 EMD Millipore 8.10.1 Company overview 8.10.2 Financial performance 8.10.3 Product benchmarking 8.10.4 Strategic initiatives 8.11 Sigma Aldrich Corporation 8.11.1 Company overview 8.11.2 Financial performance 8.11.3 Product benchmarking 8.11.4 Strategic initiatives About Grand View Research, Inc.:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Follow Us:
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: